Antoine Deslandes | Scientific Advisor Biotherapeutic Drug Disposition Sanofi R&D
Antoine Deslandes graduated in Pharmacy and received his Doctorate in Experimental and Clinical Pharmacology from the University of Paris. He joined Servier as preclinical studies manager in Psychiatry/Neurology. He then held different positions in Discovery DMPK at Parke-Davis and joined the eR&D programme at Pfizer Global R&D, as project leader of in-silico tools integration for simulation of biological processes. He then gained experience in Biotechnology as Head of MPK, at the start-up company Gencell, specialized in gene therapy. Since 2006 he works for sanofi-aventis where he initially focused on clinical PK/PD for Oncology Biotherapeutics and is now Scientific Advisor for Biotherapeutics.
Share this
Appearances at this years' conference:
Thursday 24 May 2012- Day Two
@ 17.00
Dose selection for Biologics FIH clinical Trials
- Regulatory background
- Rationale for starting dose determination
- PK/PD endpoints to support dose escalation
- Case studies
› Antoine Deslandes, Scientific Advisor Biotherapeutic Drug Disposition, Sanofi R&D